Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.21
+0.04 (0.15%)
At close: Jun 12, 2026, 4:00 PM EDT
26.19
-0.02 (-0.08%)
After-hours: Jun 12, 2026, 7:59 PM EDT

Pfizer Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21
14,45117,55716,65414,65313,71517,76317,70213,28314,87914,56913,49113,00718,48625,13522,63827,74225,66123,83824,03518,899
Revenue Growth (YoY)
5.37%-1.16%-5.92%10.31%-7.82%21.92%31.21%2.12%-19.51%-42.04%-40.41%-53.11%-27.96%5.44%-5.81%46.79%76.78%108.61%133.87%91.60%
Cost of Revenue
3,5485,2724,1723,7782,8455,9095,2633,3003,3797,5639,2693,2374,8869,6486,0638,6489,9849,7369,9326,996
Gross Profit
10,90312,28512,48210,87510,87011,85412,4399,98311,5007,0064,2229,77013,60015,48716,57519,09415,67714,10214,10311,903
Selling, General & Admin
2,9614,1623,1863,4153,0314,2743,2443,7173,4954,5753,2813,4973,4184,6453,3913,0482,5934,1042,8992,923
Depreciation & Amortization Expenses
1,1831,2301,2231,2111,2111,3591,3121,3071,3081,2671,1791,1841,1031,131822822835957968917
Research & Development
2,6273,4183,9362,4842,2123,1232,6112,7022,4932,8872,7782,6812,5263,6883,2202,8162,6565,9153,4432,458
Other Operating Expenses
9616058037211,6317505562,3617822,566336139284-51140961542-1,046-1,050-1,344
Total Operating Expenses
7,7329,4159,1487,8318,0859,5067,72310,0878,07811,2957,5747,5017,3319,4137,5737,6476,6269,9306,2604,954
Operating Income
3,1712,8703,3343,0442,7852,3484,716-1043,422-4,289-3,3522,2696,2696,0749,00211,4479,0514,1727,8436,949
Pretax Income
3,170-1,6423,3343,0442,785-104,715-1033,421-4,129-3,3522,2696,2705,2319,00111,4479,0503,8277,8436,949
Provision for Income Taxes
461-2-216141-189-421234-134293-795-964-717152303561,5701,172334-3281,123
Net Income
2,709-1,6403,5502,9032,9734114,481313,128-3,335-2,3882,3405,5555,0018,6459,8777,8783,5788,1715,825
Minority Interest in Earnings
889186887896111381566-21226
Earnings From Discontinued Operations
-130-25-7-817-5-2612-212-2134-9-186-13-236
Net Income to Common
2,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,1465,563
Net Income Growth
-9.44%--20.69%6997.56%-4.75%---98.24%-43.80%---76.51%-29.51%47.19%5.67%78.07%61.25%301.06%454.53%59.44%
Shares Outstanding (Basic)
5,6915,6865,6855,6855,6755,6675,6675,6665,6575,6475,6465,6465,6345,6155,6075,5935,6175,6165,6095,598
Shares Outstanding (Diluted)
5,7315,7225,7145,7065,7105,7035,7055,6965,6975,6475,6465,7135,7275,7435,7185,7125,7585,7685,7255,678
Shares Change (YoY)
0.37%0.33%0.16%0.18%0.23%0.99%1.04%-0.30%-0.52%-1.67%-1.26%0.02%-0.54%-0.43%-0.12%0.60%1.70%1.87%1.63%1.05%
EPS (Basic)
0.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.980.891.541.771.400.601.451.04
EPS (Diluted)
0.47-0.290.620.510.520.070.780.010.55-0.60-0.420.410.970.871.511.731.370.591.421.02
EPS Growth
-9.62%--20.51%5000.00%-5.46%---97.56%-43.30%---76.30%-29.20%47.46%6.34%69.61%59.30%293.33%446.15%64.52%
Free Cash Flow
2,1794,5034,001-1,2001,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,91210,21110,762
Free Cash Flow Growth
23.04%-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%1.49%545.04%247.39%
Free Cash Flow Per Share
0.380.790.70-0.210.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.851.781.90
Dividends Per Share
0.4300.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.3900.3900.390
Dividend Growth
-2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%2.63%2.63%
Gross Margin
75.45%69.97%74.95%74.22%79.26%66.73%70.27%75.16%77.29%48.09%31.29%75.11%73.57%61.62%73.22%68.83%61.09%59.16%58.68%62.98%
Operating Margin
21.94%16.35%20.02%20.77%20.31%13.22%26.64%-0.78%23.00%-29.44%-24.85%17.44%33.91%24.17%39.77%41.26%35.27%17.50%32.63%36.77%
Profit Margin
18.75%-9.34%21.32%19.81%21.68%2.31%25.31%0.23%21.02%-22.89%-17.70%17.99%30.05%19.90%38.19%35.60%30.70%15.01%34.00%30.82%
FCF Margin
15.08%25.65%24.02%-8.19%12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.39%30.16%22.67%26.74%22.98%20.61%42.48%56.94%
EBITDA
4,7844,5574,9964,6694,4034,1396,4711,6275,158-2,619-1,7923,8427,7567,59310,18512,62210,2385,5079,1848,257
EBITDA Margin
33.11%25.96%30.00%31.86%32.10%23.30%36.56%12.25%34.67%-17.98%-13.28%29.54%41.96%30.21%44.99%45.50%39.90%23.10%38.21%43.69%
EBIT
3,1712,8703,3343,0442,7852,3484,716-1043,422-4,289-3,3522,2696,2696,0749,00211,4479,0514,1727,8436,949
EBIT Margin
21.94%16.35%20.02%20.77%20.31%13.22%26.64%-0.78%23.00%-29.44%-24.85%17.44%33.91%24.17%39.77%41.26%35.27%17.50%32.63%36.77%
Effective Tax Rate
14.54%0.12%-6.48%4.63%-6.79%4210.00%4.96%130.10%8.56%19.25%28.76%-3.13%11.40%4.40%3.96%13.72%12.95%8.73%-4.18%16.16%
SEC Filings: 10-K · 10-Q